Abstract
Many countries consider the lifting of restrictions of social contacts (RSC). We quantify the effects of RSC for Germany. We initially employ a purely statistical approach to predicting prevalence of COVID19 if RSC were upheld after April 20. We employ these findings and feed them into our theoretical model. We find that the peak of the number of sick individuals would be reached already mid April. The number of sick individuals would fall below 1,000 at the beginning of July. When restrictions are lifted completely on April 20, the number of sick should rise quickly again from around April 27. A balance between economic and individual costs of RSC and public health objectives consists in lifting RSC for activities that have high economic benefits but low health costs. In the absence of large-scale representative testing of CoV-2 infections, these activities can most easily be identified if federal states of Germany adopted exit strategies that differ across states.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received for this research project.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Constantin Weiser are at the Johannes Gutenberg Universität Mainz, Gutenberg School of Management and Economics, Jakob-Welder-Weg 4, D-55131 Mainz, Telefon + 49.6131.39-20143, jdonsimo{at}uni-mainz.de, waelde{at}uni-mainz.de, constantin.weiser{at}uni-mainz.de. René Glawion is at the Department of Economics of Hamburg University, rene.glawion{at}uni-hamburg.de. Bodo Plachter is at the Institute for Virology of the University Medical Center Mainz, Mainz, Germany, plachter{at}uni-mainz.de. We are grateful to Claudius Gros, Albrecht Ritschl, Hilmar Schneider, Hans-Werner Sinn, to many members of the “Makrorunde” and to seminar participants of the ‘Forecasting COVID19’ workshop at the Johannes Gutenberg University for comments and discussions.
Data Availability
Data used is publicly available.